These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 35414305)
1. Efficacy of trastuzumab in HER-2-positive advanced extramammary Paget's disease. Zhu H; Lewis DJ Expert Opin Biol Ther; 2022 May; 22(5):673-674. PubMed ID: 35414305 [No Abstract] [Full Text] [Related]
2. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review. Sekiguchi N; Kubota S; Noguchi T; Fukushima T; Kobayashi T; Kanda S; Koizumi T; Miyake T; Shirai T; Okuyama R J Dermatol; 2020 Nov; 47(11):1276-1279. PubMed ID: 32706146 [TBL] [Abstract][Full Text] [Related]
3. Complete but transient clinical remission of vulvar Paget's disease with paclitaxel and trastuzumab. Isnard C; Plantier F; Thériaut M; Avril MF; Moyal-Barracco M Ann Dermatol Venereol; 2021 Mar; 148(1):47-48. PubMed ID: 33422298 [No Abstract] [Full Text] [Related]
4. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases. Kato J; Hida T; Yamashita T; Kamiya S; Horimoto K; Sato S; Takahashi H; Sawada M; Yamada M; Uhara H J Dermatol; 2018 Jan; 45(1):80-82. PubMed ID: 28891079 [TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva. Bartoletti M; Mazzeo R; De Scordilli M; Del Fabro A; Vitale MG; Bortot L; Nicoloso MS; Corsetti S; Bonotto M; Scalone S; Giorda G; Sorio R; Andreetta C; Meacci ML; De Vivo R; Fasola G; Sopracordevole F; Puglisi F Int J Gynecol Cancer; 2020 Nov; 30(11):1672-1677. PubMed ID: 32998859 [TBL] [Abstract][Full Text] [Related]
13. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy. Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751 [TBL] [Abstract][Full Text] [Related]
14. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy. Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of metastatic extramammary Paget's disease with pemetrexed monotherapy systemically and 5-fluorouracil topically. Chen K; Liang H; Peng J; Zheng Y Indian J Dermatol Venereol Leprol; 2019; 85(1):56-59. PubMed ID: 29536970 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of subclinical extramammary Paget's disease with a combination of noninvasive photodynamic diagnosis and reflectance confocal microscopy. Huang L; Wang Y; Wu M; Zhao J; Zhang W; Zhao L; Mo X; Fang F Indian J Dermatol Venereol Leprol; 2021; 87(3):371-374. PubMed ID: 30829297 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle analyses of extramammary Paget's disease. Mori O; Hachisuka H; Maeyama Y; Sasai Y Kurume Med J; 1993; 40(3):129-32. PubMed ID: 8139211 [TBL] [Abstract][Full Text] [Related]